Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

Australian scientists have used artificial intelligence to help create what's being called a "google maps approach" to cancer analysis. It enabled researchers to identify which lung cancer patients ...

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung ...

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomzed-controlled trial presented at the European Respiratory ...

The target of AllRock Bio’s research is already validated by FDA-approved medicines — for the eyes. The biotech startup is expanding that science to the lungs with a drug candidate licensed from ...

EULAR—The European Alliance of Associations for Rheumatology—has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...

Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...

Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases. Janet ...

Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) than the general population. Among IBD patients, women, older adults, and ...

Despite patients sharing a usual interstitial pneumonia (UIP) pattern on lung CT scans, patients with connective tissue disease-related interstitial lung disease (CTD-ILD) demonstrated a slower ...